ISB News

New Study Identifies Organ-Specific Biomarkers for Acute Liver Injury

ISB scientists recently published a study in the Journal of Proteome Research that presents results from a study on identifying organ-specific blood biomarkers for acute liver injury due to over-exposure to acetaminophen. From the summary:

3 Bullets:

  • Finding organ-specific blood biomarkers for disease that are clinically useful is challenging.
  • New study identifies organ-specific blood biomarkers for acute liver injury caused by over-exposure to acetaminophen.
  • ISB researchers use the powerful, targeted mass spectrometry approach of selected reaction monitoring (SRM) to identify proteins.

Adverse effects associated with therapeutic drugs are a serious health concern and a costly challenge for healthcare systems. Many drug-induced adverse effects target the liver due to their immediate exposure through first-pass pharmacokinetics and the liver’s active roles in metabolizing xenobiotics.

To assess probable injury to an organ, it is important to monitor biologic materials that originate exclusively or primarily in that organ, in this case, liver-enriched proteins. For decades, cellular integrity indicators, such as levels of the transaminases, alanine aminotransferase (ALT, GPT), and aspartate aminotransferase (AST, GOT) in serum, have been used to reflect liver injury. However, use of these enzymes as surrogate markers of liver injury is not ideal. Because they are ubiquitously expressed at similar levels in multiple organs, an interpretation of their change in levels in blood in response to a toxin can be complicated as a consequence of these enzymes originating from many tissues other than liver.

READ MORE….

Recent Articles

  • Building a Better BMI

    ISB researchers have constructed biological body mass index (BMI) measures that offer a more accurate representation of metabolic health and are more varied, informative and actionable than the traditional, long-used BMI equation. The work was published in the journal Nature Medicine. 

  • How Immune Cells ‘See’ and Respond to Mutations in Cancer Cells

    In a just-published paper in the journal Nature, a collaborative team of researchers from ISB, UCLA, PACT Pharma, and beyond analyzed T-cell responses in melanoma patients who were treated with different immune checkpoint inhibitors, and how those responses evolved over time.

  • Spotlight on ISB Education graphic

    2022-23 School Year ISB Education Highlights

    From planning, creating and executing workshops for educators to forging new relationships to elevate students, the ISB Education team has been in high gear. Each month throughout the 2022-2023 academic year, we will highlight some of the top projects the team is working on.